V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003805 | 10002398 | null | 86.8 | Curative (C) | null | 2017-04-19 | Cisplatin + Radiotherapy | null | Y | 10489599 | CISPLATIN + RT |
| 10003806 | 10002399 | null | 87 | Adjuvant (A) | null | 2017-04-20 | Azacitidine | N | N | 10489682 | CISPLATIN + ETOPOSIDE |
| 10003807 | 10002400 | 1.57 | 82.2 | Curative (C) | 2018-03-26 | 2018-03-26 | Paclitaxel 7 day | N | Y | 10489705 | CISPLATIN |
| 10003808 | 10002401 | 1.83 | null | Adjuvant (A) | 2014-03-19 | 2014-03-19 | Bortezomib + CYCLOPHOSPHAMIDE | null | N | 10489711 | CVD |
| 10003809 | 10002402 | 1.8 | 139.5 | Neo-adjuvant (N) | 2017-06-19 | 2017-06-19 | Bortezomib + Cyclophos + Dex | N | N | 10489723 | CAPECITABINE + CISPLATIN |
| 10003810 | 10002403 | 1.68 | 0 | null | 2017-07-29 | 2017-08-13 | Capecitabine + Cisplatin | N | N | 10489767 | EC |
| 10003811 | 10002404 | 1.76 | null | Palliative (P) | 2018-11-22 | 2018-12-07 | Temozolomide + RT | N | N | 10489806 | CISPLATIN + ETOPOSIDE |
| 10003812 | 10002404 | 1.62 | 75.8 | null | 2018-08-03 | 2018-08-05 | CISPLATIN + ETOPOSIDE | N | Y | 10489806 | EC |
| 10003813 | 10002405 | 0 | 71.3 | Palliative (P) | 2018-01-31 | 2018-02-21 | Fluorouricil + Folonic Acid (MdG) | N | N | 10489824 | FLUOROURACIL |
| 10003814 | 10002406 | 1.83 | 68.4 | Adjuvant (A) | 2015-12-07 | 2015-12-07 | FEC 100 + DOCETAXEL | N | N | 10489856 | FEC + DOCETAXEL |
| 10003815 | 10002407 | 1.8 | 58.5 | Palliative (P) | 2019-03-04 | 2019-03-08 | Irinotecan + Modified De Gramont | 02 | Y | 10489868 | IRINOTECAN + MDG |
| 10003816 | 10002408 | 1.62 | 79.7 | null | 2017-07-20 | 2017-08-02 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10489871 | CVD |
| 10003817 | 10002409 | 1.75 | 69.4 | Palliative (P) | 2015-10-28 | 2015-11-11 | EC | 02 | N | 10489878 | CISPLATIN |
| 10003818 | 10002409 | 1.81 | 61.8 | Palliative (P) | 2016-06-09 | 2016-06-16 | Chlorambucil | N | N | 10489878 | CVD |
| 10003819 | 10002410 | 1.66 | 101 | Curative (C) | 2016-06-25 | 2016-06-25 | CHOP - 21 days | 02 | N | 10489899 | CVD |
| 10003820 | 10002410 | 0 | 50 | Disease modification (D) | 2018-02-06 | 2018-02-21 | EC | N | N | 10489899 | TEMOZOLOMIDE + RT |
| 10003821 | 10002411 | null | null | Adjuvant (A) | 2014-05-28 | 2014-06-09 | CISPLATIN + ETOPOSIDE | N | N | 10490007 | FLUOROURACIL + MITOMYCIN + RT |
| 10003822 | 10002412 | null | 88 | Curative (C) | 2017-06-15 | 2017-06-22 | Azacitidine | N | N | 10490027 | ABVD |
| 10003823 | 10002413 | 1.75 | 68.3 | Palliative (P) | null | 2018-11-09 | EC | N | N | 10490037 | CHLORAMBUCIL |
| 10003824 | 10002413 | 1.69 | null | Palliative (P) | 2015-12-01 | 2015-12-03 | Cisplatin 7 day | null | N | 10490037 | CHLORAMBUCIL |
| 10003825 | 10002413 | 1.7 | 68.9 | Palliative (P) | 2017-09-09 | 2017-09-21 | Bortezomib +/- Dexamethasone | N | N | 10490037 | CISPLATIN + ETOPOSIDE |
| 10003826 | 10008820 | 1.77 | null | Adjuvant (A) | 2014-12-13 | 2014-12-13 | Gemcitabine + Capecitabine | N | N | 10490149 | CVD |
| 10003827 | 10002414 | 1.62 | 46 | Adjuvant (A) | 2014-12-19 | 2014-12-26 | Fluorouricil + Folonic Acid (MdG) | N | N | 10490224 | FLUOROURACIL |
| 10003828 | 10002414 | 1.51 | 66.8 | Curative (C) | 2018-01-20 | 2018-02-07 | Temozolomide + RT | N | N | 10490224 | IMATINIB |
| 10003829 | 10002415 | 1.69 | null | Palliative (P) | 2016-07-13 | 2016-07-27 | Cisplatin + Radiotherapy | N | N | 10490318 | CISPLATIN + RT |
| 10003830 | 10006517 | 1.7 | 0 | Disease modification (D) | 2018-08-13 | 2018-08-13 | Chlorambucil | N | N | 10490389 | CHLORAMBUCIL |
| 10003831 | 10006517 | 1.71 | 60 | Adjuvant (A) | 2015-01-19 | 2015-02-06 | IMATINIB | 02 | N | 10490389 | CAPECITABINE + GEMCITABINE |
| 10003832 | 10002416 | 1.58 | 85 | Disease modification (D) | 2017-08-22 | 2017-08-22 | CTD | 02 | N | 10490486 | CVD |
| 10003833 | 10002417 | 1.6 | 130.8 | Neo-adjuvant (N) | 2017-09-17 | 2017-09-17 | CAPECITABINE + RT | 2 | Y | 10490490 | CAPECITABINE + RT |
| 10003834 | 10002418 | null | 74.2 | Palliative (P) | 2017-09-18 | 2017-10-16 | Temozolomide + RT | N | N | 10490503 | BORTEZOMIB |
| 10003835 | 10002419 | 1.62 | 74 | Curative (C) | 2018-01-04 | 2018-01-15 | Capecitabine 35days + RT | 2 | N | 10490524 | CAPECITABINE + RT |
| 10003836 | 10002420 | 1.7 | 76.6 | Palliative (P) | 2015-01-24 | 2015-02-07 | Cisplatin | N | N | 10490626 | CAPECITABINE + CISPLATIN |
| 10003837 | 10002421 | 1.59 | 71.2 | Palliative (P) | 2018-02-21 | 2018-03-07 | Bortezomib +/- Dexamethasone | 02 | null | 10490760 | CAPECITABINE + GEMCITABINE |
| 10003838 | 10002422 | 1.65 | 71 | Palliative (P) | 2017-04-08 | 2017-05-02 | Irinotecan + De Gramont | N | Y | 10490771 | IRINOTECAN + MDG |
| 10003839 | 10002423 | 1.5 | 86 | Neo-adjuvant (N) | null | 2017-08-11 | PACLITAXEL | 2 | null | 10490774 | ABVD |
| 10003840 | 10002424 | 1.63 | 64.2 | Adjuvant (A) | 2016-03-25 | 2016-04-08 | FEC + DOCETAXEL | 02 | N | 10490781 | FEC + DOCETAXEL |
| 10003841 | 10002424 | 1.75 | 82.4 | Palliative (P) | 2015-12-15 | 2016-01-05 | ABVD | 02 | Y | 10490781 | CISPLATIN + ETOPOSIDE |
| 10003842 | 10002425 | 0 | 72.8 | Curative (C) | 2017-01-01 | 2017-01-07 | Chlorambucil | 2 | N | 10490897 | CVD |
| 10003843 | 10002425 | 1.72 | 101 | Palliative (P) | 2015-11-17 | 2015-11-17 | IMATINIB | 02 | N | 10490897 | FLUOROURACIL + MITOMYCIN + RT |
| 10003844 | 10002425 | 0 | 111 | Disease modification (D) | 2015-08-07 | 2015-08-13 | Cisplatin 100 + RT(H&N) 1 day | 02 | y | 10490897 | CISPLATIN + RT |
| 10003845 | 10002426 | 1.7 | 1.47 | Disease modification (D) | null | 2015-12-21 | Capecitabine + Cisplatin | 99 | N | 10490951 | EC |
| 10003846 | 10002427 | null | null | Palliative (P) | 2017-01-26 | 2017-02-13 | CHOP - 21 days | N | N | 10490973 | AZACITIDINE |
| 10003847 | 10002427 | 1.58 | 51.4 | Palliative (P) | null | 2017-03-28 | Irinotecan + Modified De Gramont | 99 | N | 10490973 | IRINOTECAN + MDG |
| 10003848 | 10002428 | 1.87 | 89 | Palliative (P) | 2018-08-09 | 2018-08-15 | Gemcitabine + Capecitabine | 02 | N | 10491016 | IMATINIB |
| 10003849 | 10002429 | 1.8 | 91.1 | Adjuvant (A) | 2016-03-05 | 2016-03-19 | FEC + DOCETAXEL | 2 | N | 10491022 | FEC + DOCETAXEL |
| 10003850 | 10002430 | 1.73 | 89 | Adjuvant (A) | 2018-12-06 | 2018-12-06 | Paclitaxel 7 day | 2 | N | 10491053 | PACLITAXEL |
| 10003851 | 10002431 | null | null | Palliative (P) | 2015-12-03 | 2015-12-09 | Capecitabine 35days + RT | N | Y | 10491171 | CAPECITABINE + RT |
| 10003852 | 10002432 | 1.73 | 82.7 | Palliative (P) | 2018-05-21 | 2018-06-13 | CISPLATIN + ETOPOSIDE | N | N | 10491181 | EC |
| 10003853 | 10002433 | 1.55 | 86.8 | Adjuvant (A) | 2014-01-09 | 2014-01-16 | Azacitidine | N | N | 10491204 | CISPLATIN |
| 10003854 | 10006521 | 1.52 | 69.5 | Curative (C) | 2017-01-09 | 2017-01-16 | Cisplatin + Radiotherapy | N | Y | 10491284 | CISPLATIN + RT |